Cargando…
A case of “smoldering” immune‐mediated thrombotic thrombocytopenic purpura manifesting as recurrent cardioembolic stroke
Prompt recognition and treatment for thrombotic thrombocytopenic purpura (TTP) are critical to prevent the irreversible manifestations of this rare and quickly fatal hematologic disorder. Untreated TTP is typically a rapid‐onset disease with mortality exceeding 90% within days in the absence of appr...
Autores principales: | Pepin, Mark E., Saca, Eyad, Kwon, Soo Y., May, Jori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507438/ https://www.ncbi.nlm.nih.gov/pubmed/34667601 http://dx.doi.org/10.1002/ccr3.4850 |
Ejemplares similares
-
Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023) -
Pitfalls in Diagnosing Thrombotic Thrombocytopenic Purpura in Sickle Cell Disease
por: Tsitsikas, Dimitris A., et al.
Publicado: (2022) -
Daratumumab for immune thrombotic thrombocytopenic purpura
por: van den Berg, Jana, et al.
Publicado: (2022) -
Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018) -
Rituximab Prevents Stroke Recurrences in Atypical Chronic Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Dupuy, Henry, et al.
Publicado: (2018)